findmyKOL

Reed Friend, MD

Basic profile

Levine Cancer Institute

ORCIDNone on fileNPI
RegionCharlotte, NC · SoutheastSpecialtyHematologyFocusHematology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Reed Friend is a Hematology physician affiliated with Levine Cancer Institute. OpenAlex indexes 61 publications with 241 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
61publications

Distinct works indexed by OpenAlex.

241citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4525 Cameron Valley Pkwy
Ste 3500
Charlotte, NC 282114369

Telephone

704-302-8300

Registry record last updated 15 Jul 2024.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    37.8%
    Kinase inhibitor18.1%
    Calquence31%Jakafi24%Tasigna16%Imatinib Mesylate15%Brukinsa13%
    Part D<11 patients
    Thalidomide Analog7.3%
    Lenalidomide53%Pomalyst48%
    Part D<11 patients

    + 2 more classes in this area

  • Dermatology

    19.4%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor19.4%
    Acyclovir100%
    Part D30 patients
  • Blood & clotting

    16.3%
    Factor Xa inhibitor11.5%
    Eliquis70%Xarelto30%
    Part D<11 patients
    Other systemic hemostatics2.7%
    Doptelet100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)8.1% facility · 91.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”